(Date:11/24/2009)...4/PRNewswire-FirstCall/--Shireplc(LSE:SHP,NASDAQ:...y,today,announcedthatithassubmittedaMAAtotheEurope...senzymereplacementtherapyindevelopment,forthetreat...applicationforvelaglucerasealfathathasbeensubmitte...da. , Basedonaglobalsupplyshortageofthecurren...
(Date:11/24/2009)...f.,Nov.24/PRNewswire-FirstCall/--GenomicHealth,Inc...icHealth,sExecutiveChairman,willpresentatthe21stAn...nTuesday,December1,2009at10:00a.m.ET. ,, Toacce...tation,visittheInvestorRelationssectionofGenomicHe....Pleaseconnecttothewebsiteatleast15minutespriortot...
(Date:11/24/2009)... Program Connects Customers with Partners Validat...NA Genotek Products , Ott..., a leading provider of products for biological sa...day announced its new global partner program. The ...notek,s partner community and is designed to help ...
(Date:11/24/2009)...RNewswire-FirstCall/--CellTherapeutics,Inc.(CTI)(N...ualPiperJaffrayHealthCareConference.Theconferencew... ,, CTIwillpresentonTuesday,December1at11:00a.m...fCTI,spresentationwillbeavailableat www.celltherap...wards. , ,PiperJaffrayHealthCareConference,NewYor...
Breaking Biology Technology:Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Genomic Health to Present at Piper Jaffray Health Care Conference 2DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3